Home > Items where Subject is "J Health care, prevention, harm reduction and rehabilitation > Risk and needs assessment > Risk assessment > Early warning monitoring system"

up arrow imageUp a level
Export as
Group by: Item Type | No Grouping
Number of items at this level: 49.

Article

Volpe, Isabelle and Brien, Rita and Grigg, Jasmin and Tzanetis, Stephanie and Crawford, Sione and Lyons, Tom and Lee, Nicole and McKinnon, Ginny and Hughes, Caitlin and Eade, Alan and Barratt, Monica J (2023) 'We don't live in a harm reduction world, we live in a prohibition world': tensions arising in the design of drug alerts. Harm Reduction Journal , 20 .

Kuropka, Patryk and Zawadzki, Marcin and Szpot, Paweł (2023) A review of synthetic cathinones emerging in recent years (2019-2022). Forensic Toxicology , 41 , pp. 25-46.

Pulver, Benedikt and Fischmann, Svenja and Gallegos, Ana and Christie, Rachel (2022) EMCDDA framework and practical guidance for naming synthetic cannabinoids. Drug Testing and Analysis , Early online .

Pulver, Benedikt and Fischmann, Svenja and Westphal, Folker and Schönberger, Torsten and Schäper, Jan and Budach, Dennis and Jacobsen-Bauer, Andrea and Dreiseitel, Wolfgang and Zagermann, Johannes and Damm, Angela and Knecht, Siegfried and Opatz, Till and Auwärter, Volker and Pütz, Michael (2022) The ADEBAR project: European and international provision of analytical data from structure elucidation and analytical characterization of NPS. Drug Testing and Analysis , 14 , (8) , pp. 1491-1502.

Mohr, Amanda L A and Logan, Barry K and Fogarty, Melissa F and Krotulski, Alex J and Papsun, Donna M and Kacinko, Sherri L and Huestis, Marilyn A and Ropero-Miller, Jeri D (2022) Reports of adverse events associated with use of novel psychoactive substances, 2017–2020: a review. Journal of Analytical Toxicology , 46 , (6) , e116-e185.

Dasgupta, Nabarun and Figgatt, Mary C (2022) Invited commentary: Drug checking for novel insights into the unregulated drug supply. American Journal of Epidemiology , 191 , (2) , pp. 248-252.

Palamar, Joseph J (2021) Moving away from piecemeal trends: the need for multiple data sources in drug use trend analyses. Drug and Alcohol Review , 40 , (6) , pp. 957-958. (Submitted)

Barenholtz, Elan and Krotulski, Alex J and Morris, Paul and Fitzgerald, Nicole D and Le, Austin and Papsun, Donna M and Logan, Barry K and Hahn, William E and Goldberger, Bruce A and Cottler, Linda B and Palamar, Joseph J (2021) Online surveillance of novel psychoactive substances (NPS): monitoring Reddit discussions as a predictor of increased NPS-related exposures. International Journal of Drug Policy , 98 .

Gunn, Christine M and Maschke, Ariel and Harris, Miriam and Schoenberger, Samantha F and Sampath, Spoorthi and Walley, Alexander Y and Bagley, Sarah M (2021) Age-based preferences for risk communication in the fentanyl era: 'A lot of people keep seeing other people die and that's not enough for them'. Addiction , 116 , (6) , pp. 1495-1504.

Varì, Maria Rosaria and Mannocchi, Giulio and Tittarelli, Roberta and Campanozzi, Laura Leondina and Nittari, Giulio and Feola, Alessandro and Umani Ronchi, Federica and Ricci, Giovanna (2020) New psychoactive substances: evolution in the exchange of information and innovative legal responses in the European Union. International Journal of Environmental Research and Public Health , 17 , (22) .

Artigiani, Eleanor Erin and Wish, Eric D (2020) Introducing the National Drug Early Warning System. Current Opinion in Psychiatry , 33 , (4) , pp. 319-325.

Rosenblum, Daniel and Unick, Jay and Ciccarone, Daniel (2020) The rapidly changing US Illicit drug market and the potential for an improved early warning system: evidence from Ohio drug crime labs. Drug and Alcohol Dependence , 208 .

Sutton, Reed T and Pincock, David and Baumgart, Daniel C and Sadowski, Daniel C and Fedorak, Richard N and Kroeker, Karen I (2020) An overview of clinical decision support systems: benefits, risks, and strategies for success. NPJ Digital Medicine , 3 .

Zaami, S (2019) New psychoactive substances: concerted efforts and common legislative answers for stemming a growing health hazard. European Review for Medical and Pharmacological Sciences , 23 , (22) , pp. 9681-9690.

Buxton, Jane A and Spearn, Bill and Amlani, Ashraf A and Kuo, Margot and Lysyshyn, Mark and Young, Sara and Purssell, Roy and Papamihali, Kristi and Mill, Christopher and Shapiro, Aaron (2019) The British Columbia Drug Overdose and Alert Partnership: interpreting and sharing timely illicit drug information to reduce harms. Journal of Community Safety and Well-Being , 4 , (1) , pp. 4-9.

Guillou, Claude and Reniero, Fabiano and Lobo Vicente, Joana and Holland, Margaret and Kolar, Kamil and Chassaigne, Hubert and Tirendi, Salvatore and Schepers, Herve (2018) Collaboration of the Joint Research Centre and European Customs Laboratories for the Identification of New Psychoactive Substances. Current Pharmaceutical Biotechnology , 19 , (2) , pp. 91-98.

Ancker, Jessica S and Edwards, Alison and Nosal, Sarah and Hauser, Diane and Mauer, Elizabeth and Kaushal, Rainu (2017) Effects of workload, work complexity, and repeated alerts on alert fatigue in a clinical decision support system. BMC Medical Informatics and Decision Making , 17 .

Genco, Emma K and Forster, Jeri E and Flaten, Hanna and Goss, Foster and Heard, Kennon J and Hoppe, Jason and Monte, Andrew A (2016) Clinically inconsequential alerts: the characteristics of opioid drug alerts and their utility in preventing adverse drug events in the emergency department. Annals of Emergency Medicine , 67 , (2) , 240-248.e3.

Mounteney, Jane and Griffiths, Paul and Sedefov, Roumen and Noor, Andre and Vicente, Julian and Simon, Roland (2016) The drug situation in Europe: an overview of data available on illicit drugs and new psychoactive substances from European monitoring in 2015. Addiction , 111 , (1) , pp. 34-48.

Brunt, Tibor M and Nagy, Constanze and Bücheli, Alexander and Martins, Daniel and Ugarte, Miren and Beduwe, Cécile and Ventura Vilamala, Mireia (2015) Drug testing in Europe: monitoring results of the Trans European Drug Information (TEDI) project. Drug Testing and Analysis , 9 , (2) , pp. 188-198.

Lee, Eva K and Mejia, Amanda F and Senior, Tal and Jose, James (2010) Improving patient safety through medical alert management: an automated decision tool to reduce alert fatigue. AMIA Annual Symposium proceedings. AMIA Symposium , 2010 , pp. 417-21.

Paterno, Marilyn D and Maviglia, Saverio M and Gorman, Paul N and Seger, Diane L and Yoshida, Eileen and Seger, Andrew C and Bates, David W and Gandhi, Tejal K (2009) Tiering drug-drug interaction alerts by severity increases compliance rates. Journal of the American Medical Informatics Association , 16 , (1) , pp. 40-46.

Report

Public Health Scotland. (2023) Rapid Action Drug Alerts and Response (RADAR) quarterly ​report. Edinburgh: Public Health Scotland.

Correlation – European Harm Reduction Network. (2022) Processes and progress of civil society monitoring of new drugs trends. Amsterdam: Correlation – European Harm Reduction Network.

National Forensic Laboratory Information System. (2022) NFLIS-Drug 2021 annual report. U.S. Drug Enforcement Administration, Diversion Control Division.

European Monitoring Centre for Drugs and Drug Addiction. (2022) New psychoactive substances: 25 years of early warning and response in Europe. An update from the EU Early Warning System. Luxembourg: Publications Office of the European Union.

Substance Abuse and Mental Health Services Administration. (2022) Drug Abuse Warning Network (DAWN): findings from drug-related emergency department visits, 2021. Rockville, MD: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration.

Linghu, Qingyuan and Peacock, Amy and Bruno, Raimondo and Sutherland, Rachel and Barratt, Monica J and Man, Nicola (2022) Trends in Google searches and social media discussions of cocaine, July 2021-June 2022: a pilot study. Sydney: National Drug and Alcohol Research Centre, UNSW Sydney.

HSE National Social Inclusion Office. (2021) Report of the Emerging Drug Trends and Drug Checking Working Group 2021. Dublin: Health Service Executive.

European Monitoring Centre for Drugs and Drug Addiction. (2020) New psychoactive substances: global markets, global threats and the COVID-19 pandemic. An update from the EU early warning system. Luxembourg: Publications Office of the European Union.

Peacock, Amy and Farrell, Michael and Muscat, Chelsea and Degenhardt, Louisa (2020) Viability of an Early Warning System (ViEWS) study: final report. Sydney: National Drug and Alcohol Research Centre, UNSW Sydney.

European Monitoring Centre for Drugs and Drug Addiction. (2019) EMCDDA operating guidelines for the European Union Early Warning System on new psychoactive substances. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2019) Using open-source information to improve the European drug monitoring system. Luxembourg: Publications Office of the European Union.

Jankovic, Jelena and Savic, Natasa (2019) Serbia Early warning system profile. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

Trimbos Instituut - the Netherlands Institute of Mental Health and Addiction. (2019) The Drugs Information and Monitoring System (DIMS) - factsheet on drug checking in the Netherlands. Amsterdam: Trimbos Instituut.

United Nations Office on Drugs and Crime. (2018) UNODC Integrated strategy on the global opioid crisis. Vienna: United Nations Office on Drugs and Crime.

European Monitoring Centre for Drugs and Drug Addiction. (2016) Perspectives on drugs: health responses to new psychoactive substances. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

Hay, Gordon and Oyston, Jane and Porcellato, Lorna and Madden, Hannah and Ross, Kim and Timpson, Hannah (2015) Evaluation of rapid access to alcohol detoxification acute referral (RADAR). Liverpool: Centre for Public Health, Liverpool John Hopkins University.

European Monitoring Centre for Drugs and Drug Addiction. Gallegos, Ana and Sedefov, Roumen (2012) Early warning system: national profiles. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. King, Leslie A and Sedefov, Roumen (2007) Early-warning system on new psychoactive substances: operating guidelines. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (2002) Early-warning system on new synthetic drugs: guidance on implementation. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

Leus, Edith and Desmet, Ann and Walckiers, Denise (2001) Development of the early warning system on new synthetic drugs at public health level in Belgium: progress report September 2001. Brussels: Scientific Institute of Public Health.

Webpage

United Nations Office on Drugs and Crime. (2022) UNODC Early warning advisory (EWA) on new psychoactive substances (NPS). URL: https://www.unodc.org/LSS/Home/NPS

United Nations Office on Drugs and Crime. (2021) Drugs monitoring platform (DMP). URL: https://dmp.unodc.org/

FactSheet

European Monitoring Centre for Drugs and Drug Addiction. (2022) Poster: Selected events from 25 years of early warning and response to new psychoactive substances in Europe. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

Dataset

United Nations Office on Drugs and Crime. (2022) Data from the UNODC early warning advisory on new psychoactive substances.

News

[EMCDDA] New legislation, bringing faster response to new drugs, applies from today. (23 Nov 2018)

[EMCDDA] New legislation published today to bring faster response to new drugs. (21 Nov 2017)

[European Commission] New psychoactive substances: Commission proposes new ban and strengthens the EU's early warning system and risk assessment . (31 Aug 2016)

This list was generated on Mon Feb 6 04:16:50 2023 GMT.